Category Archives: International Biotechnology Day 2024

International Biotechnology Day

International Biotechnology Day is an opportunity to delve into the incredible advances and potential of this discipline. Biotechnology is the use of living organisms or parts of organisms for human benefit. Although we often think of it as a modern discipline, biotechnology has been part of our history since time immemorial. Early examples of biotechnology […]

Exploring the new frontiers of biotechnology

Biotechnology has expanded our understanding and ability to address human health challenges. However, the path to clinical development of biotechnology innovations remains an intriguing challenge, with only a few innovations that have succeeded in becoming transformative tools and therapies. In this article, we explore the latest trends in healthcare biotechnology, focusing on RNA-based vaccines and […]

Oligonucleotide biosynthesis: driving precision medicine towards a sustainable future

Precision medicine has seen extraordinary advances in recent years, driven largely by research into oligonucleotide biosynthesis. These tiny fragments of nucleic acid have emerged as key players in the development of highly targeted therapies that could revolutionise the treatment of diseases ranging from genetic to complex. Oligonucleotide biosynthesis is a process in which bacteria are […]

Fire and Mello’s discovery of siRNAs: master keys to fighting disease

Small interfering RNA molecules (commonly known by the acronym siRNA small interfering RNA) represent one of the most revolutionary innovations in molecular biology and precision medicine. Their discovery, by scientists Andrew Fire and Craig Mello, was a milestone in biological research and was awarded the Nobel Prize in Physiology or Medicine in 2006. History of […]

The transformation of drug delivery in modern medicine

From the 1980s and 1990s to the present day, the field of drug delivery has undergone an extraordinary transformation that has redefined the way we administer medical treatments. This time period has seen revolutionary advances in drug delivery, driven by the convergence of nanotechnology, gene therapy and the search for more precise and effective treatments. […]

Larry Gold and Craig Tuerk: Pioneers in the Discovery of Aptamers

Advances in science and technology are often the result of the dedication, passion and collaboration of brilliant minds. One such remarkable breakthrough in the field of biotechnology is the discovery of aptamers, a class of molecules that has revolutionized research and diagnostics in biology and medicine. Larry Gold and Craig Tuerk are two names that […]

European Biotechnology Week: latest developments in the sector

The European Biotech Week 2023 (European Biotech Week #EBW2023) with various events in the different European countries. The European Biotechnology Week aims to celebrate the biotechnology sector, an innovative and vibrant sector, launched by the discovery of the DNA molecule in 1953.The first European Biotechnology Week in 2013 marked the 60th anniversary of this pivotal […]

David Bartel and microRNAs

David Bartel (Birmingham, 1958) is a leading researcher in molecular and cell biology who has made significant contributions to the field of microRNAs. His work has been instrumental in understanding the biology of miRNAs and their importance in gene regulation. Bartel is known for his work in identifying miRNAs and elucidating their role in inhibiting […]

The evolution of knowledge about RNA: from its discovery to the present day

RNA is an essential molecule for life, but its discovery and understanding has been a decades-long process. In this article, we will explore the evolution of knowledge about RNA from its discovery to the present day and how it has revolutionised our understanding of molecular biology and genetics. Introduction: What is RNA? Ribonucleic acid (RNA) […]

Enzymes: key molecules for the development of oligonucleotides

The OLIGOFASTX team is focused on the development of oligonucleotide-based therapies for certain rare diseases covering the whole cycle: from research to manufacturing and distribution of future new oligonucleotide-based drugs. To this end, the companies that make up the consortium are specialised in one area, which in combination provides a form of collaboration that allows […]